{"id":44200,"date":"2017-02-17T07:40:34","date_gmt":"2017-02-17T12:10:34","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=44200"},"modified":"2017-02-19T08:22:07","modified_gmt":"2017-02-19T12:52:07","slug":"cambios-a-biosimilares-como-y-por-que","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/44200","title":{"rendered":"Cambios a Biosimilares. C\u00f3mo y por qu\u00e9?"},"content":{"rendered":"<p style=\"text-align: center;\"><a href=\"https:\/\/drive.google.com\/file\/d\/0B36xYqp27ArvV1JpSmxFaDd4ZTg\/view?usp=sharing\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-44201\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2017\/02\/psoriasis-405.jpg\" alt=\"\" width=\"491\" height=\"311\" srcset=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2017\/02\/psoriasis-405.jpg 491w, https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2017\/02\/psoriasis-405-390x247.jpg 390w\" sizes=\"auto, (max-width: 491px) 100vw, 491px\" \/><\/a><\/p>\n<p style=\"text-align: center;\">CLIC EN LA IMAGEN PARA VER LA PRESENTACI\u00d3N<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Los pacientes tratados con biol\u00f3gicos que presentan una respuesta inadecuada o un efecto adverso intolerable, puede y\/o deben cambiarse a otro agente biol\u00f3gico por razones cl\u00ednicas<\/p>\n","protected":false},"author":99,"featured_media":44201,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[276],"tags":[],"class_list":["post-44200","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-psoriasis-y-eccema"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/44200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/99"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=44200"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/44200\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/44201"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=44200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=44200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=44200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}